Hillary’s vaccine price plan didn’t work the first time for a reason

The zombie scheme to control drug costs by having the government set prices is back from the dead.

Pundits in Forbes, The New Yorker and the Huffington Post have been raging about the “unsustainable” price of new cancer drugs all year. But anger about drug prices really went viral when Martin Shkreli, the CEO of Turing Pharmaceuticals, hiked the price of a generic tuberculosis drug he acquired by 5,000 percent.

Now price-control proposals are on the ballot in California, Ohio, Massachusetts and other states. Unsurprisingly, such plans are supported and encouraged by Hillary Rodham Clinton, who warned she’d rein in prices.

Biotechnology stocks fell: Investors remembered what happened the last time Clinton went on a price-control mission.

But not everyone does. To refresh:

As first lady and in charge of the Bill Clinton administration’s health-care reform effort, Hillary accused “greedy” drug companies of exorbitant price increases for vaccines. In 1993, she first proposed nationalizing the vaccine industry. She settled for a Vaccines for Children Program that saw the federal government buy up over half of all available vaccines at government-set prices.
Sign Up for Our Email Newsletter

RECENT NEWS

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

CMPI & NCPA Forum Panel Two discussion: Principles for PBM Reform and Patient Centered Prescription Drug Benefits...  Read more

Keynote Speech: A. Mark Fendrick, M.D.

Keynote Speech: A. Mark Fendrick, M.D.

CMPI & NCPA Forum Keynote Speech: Mark Fendrick, M.D., Director, Center for Value Based Insurance Design, University of M...  Read more

How PBMs Affect Access and Affordability

How PBMs Affect Access and Affordability

CMPI & NCPA Forum Panel One discussion: How PBMs Affect Access and Affordability...  Read more

DRUGWONKS BLOG